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ABSTRACT  
In severe liver injury ductular reactions (DRs) containing bipotential hepatic progenitor cells (HPCs) 
branch from the portal tract. Neural cell adhesion molecule (NCAM) marks bile ducts and DRs but not 
mature hepatocytes. NCAM mediates interactions between cells and surrounding matrix, however its 
role in liver development and regeneration is undefined. Polysialic acid (polySia), a unique 
posttranslational modifier of NCAM is produced by the enzymes ST8SiaII and ST8SiaIV and weakens 
NCAM interactions. The role of the polySia with NCAM synthesising enzymes St8SiaII and St8SiaIV 
were examined in HPCs in vivo using the CDE and DDC diet models of liver injury and regeneration, 
in vitro using models of proliferation, differentiation and migration and by use of mouse models with 
gene defects in the polysialyltransferases (St8sia 2+/-4+/-, and St8sia2-/-4-/-). We show that during liver 
development, polySia is required for the correct formation of bile ducts as gene defects in both the 
polysialyltransferases (St8sia2+/-4+/- and St8sia2-/-4-/- mice) caused abnormal bile duct development. In 
normal liver there is minimal polySia production and few ductular NCAM+ cells. Following injury 
NCAM+ cells expand and polySia is produced by DRs/HPCs through ST8SiaIV. PolySia weakens 
cell-cell and cell-matrix interactions facilitating HGF induced migration. Differentiation of HPC to 
hepatocytes in vitro results in both transcriptional down-regulation of polySia and cleavage of 
polySia-NCAM. Cleavage of polySia by endosialidase (endoN) during liver regeneration reduces 
migration of DRs into parenchyma. Conclusion: We conclude that polySia modification of NCAM+ 
ductules weakens cell-cell and cell-matrix interactions allowing DRs/HPCs to migrate for normal 
development and regeneration. Modulation of polySia levels may provide a therapeutic option in liver 
regeneration.   
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INTRODUCTION 
The normal liver regenerates efficiently through hepatocyte division. However, in chronic or severe 
liver injury a second regenerative compartment is activated termed the ductular reaction (DR)1. In 
severe liver injury DRs spread from the periportal area into the hepatic parenchyma. Hepatic 
progenitor cells (HPCs) are thought to reside in the Canal of Hering and expand after severe or 
chronic liver damage and regenerate hepatocytes and cholangiocytes. Clonogenic bipotential HPCs 
can be isolated from mice with DRs2 and recent lineage tracing in mouse models of liver injury 
demonstrated that HPCs within the DR can regenerate parenchyma3. A stereotypical niche of cellular 
components (myofibroblasts and macrophages) which direct HPC mediated liver regeneration via 
Notch and Wnt signalling4 surrounds the DRs5. Laminin matrix surrounds the DRs and may influence 
HPC behaviour. There is little information regarding the mechanisms controlling migration of 
HPCs/DRs or the detachment of cells from the cellular or acellular components of the niche5.  
In this report we have examined the functional role of the DR/HPC marker NCAM (neural cell 
adhesion molecule) and its typical posttranslational modification polysialic acid (polySia) in the 
DR/HPC niche. NCAM is a prototypic member of the immunoglobulin (Ig) family of adhesion 
molecules6. NCAM has three major isoforms; NCAM-120 (120kDa), -140 (140kDa) and -180 (180kDa). 
NCAM mediates cell-cell adhesion by multiple modes including homophilic and heterophilic 
interactions and cell-matrix contact7. These interactions are modified by the posttranslational 
modification of NCAM with polySia. Two Golgi-resident polysialyltransferases (polySTs) ST8SiaII and 
ST8SiaIV exist and transfer polySia onto complex N-glycans located in the fifth Ig-like domain of 
NCAM8. The enzymes ST8SiaII and ST8SiaIV are independently able to transfer polySia onto NCAM9.  
Due to the size of the polySia chains and their high water binding capacity polySia on NCAM 
(polySia-NCAM) changes NCAM functions from adhesive to anti-adhesive10. Accordingly, 
polySia-NCAM has been implicated in dynamic processes such as cell migration and plasticity in the 
nervous system11. The crucial role of polySia in ontogeny is highlighted by the lethal phenotype of 
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mice lacking two polySTs12. Mice with only partially depleted polySia synthetic capacity exhibit distinct 
but milder phenotypes13. The only known polySia degrading enzyme is endosialidase (endoN), a 
phage born enzyme14. Due to its stability and selectivity, endoN has been used in numerous animal 
models without producing adverse effects and we have therefore used endoN here to cleave 
polySia15.  
The liver has been described as an organ with low NCAM and polySia expression12. However, NCAM 
can be detected on specific cells in liver injury. Knittel et al. (1996) and Nakatani et al. (1996 and 
2006) reported NCAM+ hepatic stellate cells and portal fibroblast in rat and human liver16-18. Fabris et 
al. (2000) reported that human reactive ductules with atypical morphology coexpressed NCAM19, 20. 
Zhou et al. (2007) provided evidence that NCAM+ cells in the DRs represent bipotent HPCs in 
human21. This study and our previous study22 showed NCAM expression in bile ducts and a wide 
range of human DRs. Importantly those DRs immediately adjacent to mature hepatocytes were NCAM 
negative21. The biological functions of NCAM have not been previously reported in liver. Given that cell 
proliferation and migration from the niche is seen in liver regeneration, we hypothesized that the 
antagonistic functions of NCAM and polySia-NCAM in the regulation of cell adhesion and cell 
migration (proven for the nervous tissue) may play a significant role during liver development and 
regeneration.  
Here we show for the first time the expression of polySia in the liver. PolySia was found to increase 
markedly after liver damage and facilitated the migration of the DRs/HPCs away from the periportal 
niche during liver regeneration. Furthermore polySia and its carrier NCAM were reduced during the 
differentiation of HPCs to mature hepatocytes.  
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MATERIALS AND METHODS  
Mice 
Animals were housed in a specific pathogen free environment and kept under standard conditions with 
a 12 hour day/night cycle and access to food and water ad libitum. All animal experiments had local 
ethical approval and were conducted according to UK Home Office Legislation. Male mice were fed 
either CDE (Choline Deficient Diet with 0.15% Ethionine diet; Sigma-Aldrich, St Louis, MO) or DDC 
diet (3,5-diethoxycarbonyl-1,4-dihydrocollidine; 0.1% Purina 5015 mouse chow) for 11 days to 
C57BL/6 mice (n=6, 7 weeks old) and S129P2 mice (n=6, Halran Laboratories, Inc. Indianapolis, IN, 
10 weeks old) respectively for immunohistochemistry and real-time PCR. To analyse the effect of 
endoN during liver development, 6 wild type mice, 7 double heterozygous St8sia2+/-4+/- mice and 12 
double knock out St8sia2-/-4-/- mice (provided by Professor Rita Gerardy-Schahn, Hannover University) 
were analysed. All wild type and St8sia mutant mice were sacrificed at day P8.5-P9.5. To analyse the 
effect of endoN during liver regeneration, S129P2 mice (more than 10 weeks old) were fed DDC diet 
for 16 days. Induction of polySia was significantly higher in DDC diet mouse liver compared to CDE 
diet mouse liver (Figure 1C and D), thus we employed the DDC diet mice in this experiment. To 
determine an effective dose of endoN that would work in vivo, we injected 3.14-19.69 µg of endoN/g of 
mouse in a single intraperitoneal injection on day 15 of a 16 day DDC injury protocol. While all of the 
control injected mice were positive for polySia in western blots of whole liver tissue lysates, polySia 
could not be detected in the endoN injected mouse liver tissue lysates (Supplemental figure 8B). As 
side effects were not seen with any endoN dose, 5µg/g/injection of endoN was used in the subsequent 
experiment and was injected 4 times (days 8, 10, 12 and 14) intraperitoneally during the 16 day DDC 
experiment (Supplemental figure 8A). Mice were divided into two groups, one group received endoN 
(n=10) and control mice received vehicle (n=9). Histological analysis, liver weight/body weight 
(LW/BW) ratio, serum blood tests and real-time PCR were performed for analysis. Serum was 
analysed using commercial kits for: Alanine aminotranspherase (ALT; Alpha Laboratories Ltd, 
Eastleigh, UK), Albumin (Olympus Diagnostics Ltd, Southend-on Sea, UK), Aspartate 
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Aminotransferase (AST) and Alkaline Phosphatase (ALP) (both Randox Laboratories, London, UK) 
according to manufacturer's instructions. 
 
Further description of the materials and methods used are provided in the supplemental file. 
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RESULTS 
NCAM+ DRs expand from the periportal area after liver injury 
We studied immunohistochemistry for NCAM from mouse models of hepatocellular injury and 
regeneration (CDE diet) and from biliary injury and regeneration (DDC diet). In normal livers, a few bile 
duct cells and their surrounding cells were positive for NCAM, however after liver damage NCAM+ 
DRs and closely associated NCAM+ niche cells began to expand from the portal area and spread into 
the parenchyma in both hepatocellular and biliary injury (Figure 1A and B). These results suggested 
that NCAM+ cells are at least two populations, the epithelial cells of the DR and their surrounding 
niche cells following liver damage.  
 
ST8SiaIV is the main polysialyltransferase expressed in damaged mouse livers  
Two enzymes, the polySTs ST8SiaII and IV are independently able to transfer polySia onto NCAM. 
The levels of polyST transcripts have been demonstrated to tightly correlate with the level of polySia 
expression23. To identify the polySTs responsible for NCAM polysialylation in the liver, the gene 
expression levels were determined in parallel to Ncam expression in the CDE and DDC damaged 
livers. Both diets (CDE shown in Figure 1C and DDC in Figure 1D) led to a significant increase in the 
expression of Ncam and St8sia4, while the expression of St8sia2 remained at the level of control 
tissue. Since the product formation by polySTs has been described to be tightly linked to the mRNA 
expression level this data provides strong evidence that polySia production in damaged livers results 
from ST8SiaIV activity23. 
 
Ductular cells and myofibroblasts surrounding the DRs are NCAM+ and polySia is 
predominantly expressed at the lateral cell surface of bile ducts and DRs   
To precisely define the NCAM+ cells associated with the DRs in 11 day DDC damaged livers, double 
fluorescence immunohistochemistry was performed using NCAM together with markers for bile ducts 
and DRs (panCK and sox9; panCK can stain bile ducts and DRs/HPCs in the same manner with 
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cytokeratin19 (CK19) as Supplemental figure 1A and B. Both anti-panCK and anti-CK19 antibodies 
were used in this study), hepatic stellate cells (desmin and GFAP), myofibroblasts (α-SMA and 
desmin) and hematopoietic cells (CD45). Double immunofluorescence between NCAM, and panCK 
(Figure 2A and Supplemental figure 2A) and sox9 (Figure 2B and Supplemental figure 2B) revealed 
that bile duct and DRs (epithelial cells) frequently expressed NCAM, together with surrounding 
(non-epithelial) cells. α-SMA+/NCAM+ cells and desmin+/NCAM+ cells were identified to associate 
with the DRs, however, α-SMA-/NCAM+ and desmin-/NCAM+ cells were also detected in this area 
(Figure 2C and Supplemental figure 2C). We could not detect GFAP+/NCAM+ cells (Supplemental 
figure 2D) or CD45+/NCAM+ cells (Supplemental figure 2E). These results revealed that there are 
NCAM+ myofibroblasts associated with the DRs. When the relationship between NCAM+ cells and 
laminin (Supplemental figure 2F) was analysed in the DRs, it was found that almost all NCAM+ cells 
made contact with laminin. PolySia was predominantly located at the lateral cell surface of bile ducts 
and DRs (Figure 2D). NCAM and polySia also could be detected in the same manner in the long term 
(8 weeks) DDC damaged livers (Supplemental figure 2G and H) suggesting that polySia-NCAM 
system is perpetuated during liver damage. Furthermore to analyse polySia-NCAM in human chronic 
liver diseases, we immunostained for CK19, NCAM and polySia using serial sections of cirrhotic liver 
tissues caused by hepatitis C virus (HCV), alcohol and primary biliary cirrhosis (PBC). All of these 
human diseases expressed NCAM and polySia in DRs suggesting that polySia-NCAM is present in 
human chronic liver diseases (Figure 3E).         
 
PolySia weakens cell-matrix interactions, prevents cell aggregation and promotes HGF induced 
migration of HPCs in HPC culture models 
To analyse the role of polySia we stained three HPC lines, previous characterized HPC line BMOL 24 
and our two established cell lines (HPC line 2 and 3), for NCAM and polySia. All of the HPC lines 
expressed NCAM and polySia (Figure 3A and Supplemental figure 3A and B). BMOLs had 6 times the 
expression level of polySia compared to other two HPC lines (Supplemental figure 3C) and showed 
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typical gene changes seen during a differentiation protocol induced by Wnt3A or OSM with a decrease 
in Ck19 and an increase in the hepatocyte markers Alb (Supplemental figure 4A and C). HGF induced 
relatively weak differentiation (Supplemental figure 4B), but induced HPC expansion and migration in 
vitro (Figure 3C and E). Therefore the BMOL cells are an ideal HPC line for further analysis of polySia 
and NCAM. Flow cytometric analysis revealed that BMOLs are almost all positive for NCAM but have 
varying levels of polySia positivity (Figure 3A). To investigate the polySia-NCAM relationship further 
western blot analysis for NCAM was performed using wild type P1.5 neonatal mouse brain (known to 
contain abundant polySia-NCAM as positive control), P1.5 NCAM knock out neonatal mouse brain 
(negative control) and BMOLs with or without endoN. Without endoN a diffuse signal around 200kDa 
was seen which showed polySia with NCAM in wild type P1.5 neonatal mouse brain lane and BMOLs 
lane. After treatment with polySia specific endoN, bands were concentrated at 180kDa and 140kDa in 
the wild type P1.5 neonatal mouse brain lane and at 140kDa in BMOLs lane respectively. In NCAM 
knock out mouse lanes no band could be detected (Figure 3A). To confirm the relationship between 
NCAM and polySia further co-immunoprecipitation was performed. Following immunoprecipitation for 
NCAM, immunoprecipitates were blotted for NCAM and polySia. This showed the polySia with NCAM 
diffuse signal (around 200kDa) in both groups. After endoN digestion, western blot for NCAM showed 
that this signal was concentrated at 140kDa (Supplemental figure 5). All of these results indicate that 
NCAM-140 is the main carrier of polySia in the BMOL HPC cell line (Figure 3A). As seen in whole 
mouse liver, St8sia4 was also the main polyST in BMOL by RT-PCR (Supplemental figure 6A). We 
examined the laminin-BMOL cell-matrix interaction by seeding BMOL cells on laminin-coated plates for 
30 minutes. Pre-treatment with endoN significantly increased cell adhesion compared to control 
(Figure 3B) suggesting that polySia weakens the cell-matrix interaction in the HPC niche.     
We examined whether polySia impacts upon HPC expansion, aggregation, and migration with or 
without endoN. We assessed BMOL expansion with or without HGF having confirmed that cell 
expansion induced by HGF for 3 days culture did not affect NCAM expression levels in the BMOLs 
(Supplemental figure 6B). In both groups, cleavage of polySia by endoN did not affect cell expansion 
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(Figure 3C). In contrast aggregation assays revealed that the presence of endoN decreased (>10%) 
significantly the ratio of single cells/total cells (55.1±3.1 vs 44.9±3.3%) (Figure 3D), suggesting that 
polySia inhibits formation of stable cell-cell aggregation. Migration assays with a strong migratory 
stimulation factor HGF showed that endoN significantly decreased cell migration (6.53±0.28e5 pixel vs 
5.93±0.26e5 pixel), however in the absence of migratory stimulation the difference was not obvious 
(Figure 3E). Taken together these results sugget that polySia inhibits cell-cell and cell-matrix 
interactions and promotes HPC migration in response to HGF. 
 
PolySia-NCAM is cleaved during differentiation of HPCs to hepatocytes by OSM 
While DRs/HPCs themselves express polySia and NCAM, hepatocytes were negative for both factors 
suggesting that during differentiation, polySia-NCAM disappears from the cell surface of HPCs. We 
therefore checked the fate of polySia during differentiation to hepatocyte-like cells through the addition 
of Wnt3A, HGF and OSM to BMOLs25 by flow cytometry and found that the frequency of polySia+ cells 
decreased significantly compared to untreated cells (Figure 4A and B) 2 and 4 days after the addition 
of Wnt3A, HGF and OSM. Four days following the addition of OSM the frequency of polySia+ cells 
decreased markedly. We further checked the effect of Wnt3A, HGF and OSM upon polySia 
transcription by looking for changes in Ncam and St8sia4 mRNA at day1. Wnt3A and HGF decreased 
St8sia4 mRNA at day1 and the frequency of polySia+ cells by flow cytometry at day2 suggesting that 
Wnt3A and HGF decreased polySia at the transcriptional level. However OSM increased Ncam and 
St8sia4 gene expression at day1 and decreased the frequency of polySia+ cells by flow cytometry 
significantly at day2 indicating that during OSM induced differentiation the reduction in polySia+ cells 
was not mediated at the transcriptional level (Figure 4C). Because the antibody used in flow cytometry 
recognized polySia and not NCAM, to resolve the mechanism of polySia disappearance western blot 
for NCAM using 24h BMOL cultures separated into cell lysate and supernatant was performed. This 
revealed that the protein level of NCAM after endoN treatment in BMOL cell lysate decreased after 
addition of OSM (Figure 4D) and the protein level of NCAM after endoN treatment in the BMOL 
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supernatant increased after the addition of OSM (Figure 4E). These results support the idea that 
NCAM was cleaved and released to the supernatant during differentiation.                  
 
Hepatic myofibroblasts contain NCAM+ cells with low polySia expression in vitro         
We previously identified NCAM+ DR-associated myofibroblasts and we therefore established two 
non-epithelial NCAM+ cell lines from CDE damaged livers; (non-hepatic progenitor cell neural cell 
adhesion molecule positive cells) NHNPC1 and NHNPC2. Both sub-fractions contained NCAM+ and 
α-SMA+ cells (Figure 5A). Both fibroblastic cell lines contained hepatic myofibroblasts that expressed 
mRNA for myofibroblasts (α-sma, Fibulin-2, Collagen-1 and Desmin) but were negative for the 
inactivated hepatic stellate cell marker Gfap (Figure 5B). Importantly flow cytometric analysis revealed 
that while the polySia expression levels in HPC cell lines were high (Supplemental figure 3C), polySia 
expression levels in NHNPCs were low (Figure 5C). 
 
EndoN digestion of polySia reduces HPC migration in co-cultures with myofibroblasts  
We analysed BMOL migration with myofibroblasts to model the cellular interactions in the damaged 
regenerating liver. We therefore modeled an “artificial niche” by culturing BMOLs upon a NHNPC1 cell 
layer with or without endoN (Figure 5D). Time lapse photography revealed that red stained BMOLs 
readily migrate over the myofibroblasts, however in the presence of endoN the mobility of the BMOLs 
was significantly decreased (Supplemental video 1; control and 2; with endoN). The average distance 
of migration dropped by >30% (from 97.4±47.0µm to 62.1±31.6µm) in endoN containing cultures 
(Figure 5E) indicating that polySia weakens the HPC cell-cell interaction and thus aids migration of the 
DRs/HPCs.           
 
PolySia is required for the correct formation of bile ducts 
We isolated and expanded fetal HPCs from C57BL/6 mice25 and confirmed that they expressed NCAM 
(Figure 6A) and polySia (Figure 6B). To understand further the role of polySia in liver development we 
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analysed the neonatal (8.5-9.5 days after birth) livers of wild type, heterozygous St8sia2+/-4+/- and 
double knock out St8sia2-/-4-/- mice. Since most of the double KO mice die within 20 days after birth, 
we analysed the livers from 8.5-9.5 day old neonatal mice. H&E staining of these livers revealed an 
obvious difference between wild type livers and St8sia2+/-4+/- or St8sia2-/-4-/- mice which lacked proper 
bile duct structures (Figure 6C). To confirm this we performed immunohistochemistry for panCK 
(Figure 6C) and quantified the tube forming bile ducts (bile ducts with typical morphology)/portal area 
in all groups. The frequency of tube forming bile ducts/portal area in St8sia2+/-4+/- and St8sia2-/-4-/- mice 
group was decreased significantly compared to the wild type group (Figure 6D, Supplemental figure 7). 
We performed real-time PCR using bile duct and HPC markers (Ck19 and Ggt and Sox9, Prominin-1, 
Ncam and Epcam) and hepatocyte markers (Alb, Tat, Cps1, To, G6p, Cyp1a2 and Cyp2a12) from 
each group. There were no significant differences between wild type and St8sia2+/-4+/- mice except the 
increase of the mRNA levels of Ck19, which is expressed in bile ducts and DRs, in St8sia2+/-4+/- mice. 
In contrast, there were marked differences between wild type and St8sia2-/-4-/- mice with up-regulation 
of many biliary and HPC marker genes in St8sia2-/-4-/- mice (Figure 6E).  
 
PolySia is required for the migration of DRs into the liver parenchyma in the DDC diet liver 
damage model  
To confirm the role of polySia during liver regeneration in vivo, we injected mice intraperitoneally with 
endoN during the DDC induced liver injury protocol (Supplemental figure 8A).  
Most obvious difference was the formation of DRs. In endoN injected group most of the DRs stayed in 
the portal area, in contrast in control group DRs migrating into the liver parenchymal area were more 
obvious (Figure 7A and B, and Supplemental figure 9). Furthermore, in the endoN injection group the 
liver weight/body weight (LW/BW) ratio was lower and serum levels of alanine aminotransferase (ALT) 
were higher compared to the control injection group (Figure 7C and D). Finally, we cecked the mRNA 
expression of bile duct and HPC markers (Ck19 and Ggt and Sox9, Prominin-1, Ncam and Epcam), 
hepatocyte markers (Alb, Tat, Cps1, To, G6p, Cyp1a2 and Cyp2a12) and fibrosis related markers 
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(α-sma, Desmin and Collagen-1). The mRNA of Ck19, Alb, Tat, Cps1 and Collagen-1 were increased 
in the endoN injection group compared to controls (Figure 7E). Overall, these results suggest that the 
endoN injection cleaves the hepatic polySia, resulting in less ductular migration and an increase 
susceptibility to hepatocellular injury during DDC diet liver damage.   
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DISCUSSION 
The regeneration of hepatocytes and biliary epithelia by HPCs has been demonstrated using lineage 
tracing techniques26. However, the trigger for the formation of the DRs and detachment of HPCs from 
the niche into hepatocytes or bile ducts is not well understood. PolySia, through its action in 
weakening cell-cell and cell-matrix interactions contributes to this important step during liver 
regeneration. 
In the brain, the roles of NCAM and polySia have been extensively analysed and the physicochemical 
properties of the large and highly hydrated polySia have been implicated in the modulation of cell-cell 
contact. The presence of polySia enhances migration of neural progenitor cells and the growth and 
targeting of axons11. Our studies have shown that in the normal liver NCAM expressing cells are very 
limited in number and are confined to bile duct cells and fibroblasts near the portal tract. However, 
after liver damage, NCAM+ cells and polySia production begin to increase in the area of the DR/HPC 
niche. Both ductular and non-ductular cells surrounding the DR express NCAM. HPCs have high 
levels of polySia and the main HPC polyST was ST8SiaIV, whilst myofibroblasts have low levels of 
polySia expression. In damaged livers the main polyST was ST8SiaIV, which is consistent with a 
predominant HPC source. From these results, we conclude that HPCs produce polySia mainly through 
ST8SiaIV, and that this is the main mechanism by which polySia is produced in the DR/HPC niche of 
damaged livers. PolySia is predominantly expressed at the lateral cell surface of the DRs and bile 
ducts. In vitro studies using a HPC cell line revealed that polySia weakens cell-matrix interaction and 
cell-cell aggregation of HPCs and increases HGF induced HPC migration. While the NCAM 
expression in HPCs is described, the fate of NCAM is not known as their progeny the hepatocytes do 
not express NCAM. Here we show that NCAM is cleaved during OSM induced differentiation of HPCs 
to hepatocytes and suggest it likely that NCAM and polySia-NCAM is cleaved from HPCs as soluble 
NCAM during the differentiation of HPCs into hepatocytes in damaged livers.  
                          
In mice lacking polySia expression (St8sia2-/-4-/- double knock-out mice), severe phenotypic alterations 
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have been described in the brain suggesting a lack of neural plasticity due to a precocious 
presentation of polySia free NCAM forms12. In the liver of neonatal double knock-out mice, tube 
forming bile duct formation was inhibited and many HPC markers and bile duct markers were 
up-regulated, suggesting that polySia is required for correct liver as well as brain development. 
The role of polySia in liver regeneration was analysed in the DDC induced liver damage model by 
repeated endoN injection. DRs/HPCs in the endoN injected polySia cleaved mice migrated less 
compared to controls suggested that polySia promotes effective migration of DRs/HPCs during liver 
regeneration. This endoN injected mice were increased susceptibility to liver damage with increasing 
the serum levels of ALT compared to controls. Adverse effects of endoN have not been reported to 
date, however from these experiments we found that endoN may exacerbate hepatocellular injury. We 
would therefore not advocate the clinical use of this compound in the setting of liver injury.       
 
Data showing the presence of polySia-NCAM on short-term and long-term mouse DRs and on human 
DRs in chronic liver diseases suggest polySia-NCAM system is perpetuated during liver damage, is 
not species-specific and has potential relevance in human liver disease. Recently other function of 
polySia is reported including a role as a reservoir for neurotrophic factors and neurotransmitters27. It 
will be interesting in future studies to determine whether polySia has such roles in liver development 
and regeneration. 
 
NCAM is by far the best characterized and major polySia carrier28, however recently other polySia 
binding protein such as SynCAM129, neuropilin-230 and Myristoylated Alanine-rich C kinase Substrate 
(MARCKS)31 have been reported. Of these binding proteins polysialylation of SynCAM1 strikingly 
depends on the presence of ST8SiaII28, which is expressed at very low levels in the liver compared to 
ST8SiaIV, making it highly unlikely that SynCAM1 is the major polySia binding protein in the liver. We 
checked the immune-expression of neuropilin-2 and MARCKS in CDE and DDC damaged liver tissues 
and in BMOL cells. Only neuropilin-2 could be detected, and was restricted to endothelial cells of 
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damaged livers, suggesting that these 2 proteins are not binding protein in the liver. We therefore 
concluded that NCAM is the major binding protein of polySia in liver, a similar situation to that seen in 
the brain (Supplemental figure 10). 
 
Here we propose a 3 step mechanism for NCAM and polySia in liver regeneration: 1) NCAM 
contributes to the cell-cell and cell-matrix interaction of HPCs in the un-activated HPC niche in normal 
liver. 2) During liver damage, polySia facilitates DR and HPC cell migration. 3) During the 
differentiation of HPCs to hepatocytes, NCAM is cleaved from the cell surface (Figure 8). We believe 
this 3 step NCAM, polySia-NCAM system modulates liver regeneration and importantly stops the 
further migration of cells once differentiated. Blockade of this “cellular lubrication system” can result in 
impaired DRs and liver regeneration. The therapeutic modulation of polySia levels and polySia-NCAM 
interactions may therefore be worth exploring in future studies.  
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FIGURE LEGENDS 
Figure 1. NCAM expression of normal and damaged livers in mouse by immunohistochemistry. The 
mRNA expression change of Ncam, St8sia2 and St8sia4. (A-B) NCAM expression in normal mouse 
livers and CDE (A) and DDC (B) diet induced damaged livers. In normal mouse livers NCAM+ cells 
could be detected only on bile ducts or bile duct surrounding cells. After liver damage, NCAM+ DRs 
and their surrounding cells expanded aggressively from the portal tract in both liver damage models. 
(C-D) The mRNA change of Ncam, St8sia2 and St8sia4 before and after CDE and DDC diet induced 
liver damage. After liver damage, while the mRNA of Ncam and St8sia4 increased significantly in both 
models, the mRNA levels of St8sia2 did not change significantly. Scale bar = 100µm.                  
 
Figure 2. Characterization of NCAM+ cells and localisation of polySia+ cells in damaged livers by 
immunofluorescence staining. NCAM and polySia expression in human damaged livers. (A and B) 
Double immunofluorescence staining between NCAM and the ductular/HPC marker panCK (A) and 
sox9 (B) revealed that some cells of the bile duct and DR expressed NCAM (A and B; yellow arrows). 
Some cells surrounding the DR also expressed NCAM (A and B; green arrows). (C) Double 
immunofluorescence staining between NCAM and myofibroblast marker α-SMA revealed that some of 
the non-ductular NCAM+ cells were α-SMA+ myofibroblasts (C; yellow arrow. Green arrow shows 
α-SMA-/NCAM+ cells). (D) Immunofluorescence staining for polySia revealed that polySia was 
predominantly expressed at lateral cell surface of DRs (CK19+ cells were showed by serial section). 
(E) Immunohistochemistry using serial sections showed that chronic damaged human livers caused by 
hepatitis C virus (HCV), alcohol and primary biliary cirrhosis (PBC) also expressed NCAM and polySia 
on CK19+ DRs. Scale bar = 100µm (A and C) and 50µm (B, D and E).            
 
Figure 3. Analysis of the role of polySia in vitro. (A) Double immunofluorescence staining for NCAM 
and polySia revealed that BMOL cells were positive for NCAM and polySia. Flow cytometric analysis 
showed that almost all cells are positive for NCAM some of which were positive for polySia with 
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different levels. Western blot analysis for NCAM without endoN revealed that anti-NCAM antibody 
detected diffuse signal, corresponding to polySia with NCAM, on lanes of P1.5 wild type mouse brain 
and BMOLs. After cleavage of polySia by endoN the bands were concentrated at 180kDa and 140kDa 
in P1.5 wild type mouse brain lane, and at 140 kDa in BMOLs lane. In lanes of NCAM knock out 
mouse brain no band could be detected. (B) Adhesion assay. After addition of endoN the number of 
adherent cells to laminin increased. (C) Cleavage of polySia by endoN did not affect cell expansion, 
even in the presence of HGF. (D) Aggregation assay. After the cleavage of polySia by endoN, the 
frequency of single cells/total cells decreased significantly indicating greater cell-cell aggregation. (E) 
Migration assay. Cleavage of polySia by endoN decreased HGF induced cell migration significantly 
compared with control (no endoN) (Dotted lines show the distal end of migrated cells). Scale bar = 
100µm.           
 
Figure 4. The fate of polySia-NCAM during differentiation of HPCs to hepatocytes in vitro. (A) Flow 
cytometric analysis using BMOLs cultured for 2 (A) and 4 days (B) in differentiation conditions (Wnt3A, 
HGF, OSM vs control) markedly decreased the frequency of polySia+ cells. Especially 4 days after 
addition of OSM strikingly decreased polySia. (C) While addition of Wnt3A and HGF decreased the 
mRNA of St8sia4, addition of OSM increased the mRNA of Ncam and St8sia4 at day1 despite the 
frequency of polySia decreased at day2. (D) Western blot analysis of BMOL cell lysate with endoN 
after addition of OSM showed loss of NCAM protein. (E) In contrast, the western blot analysis of the 
BMOL culture media supernatant with endoN revealed that the addition of OSM increased the NCAM 
protein in the supernatant.  
 
Figure 5. Characterization NCAM+ myofibroblasts and migration of the HPCs in the presence of 
NCAM+ myofibroblasts. (A) We characterised 2 cells lines NHNPC1 and NHNPC2 as myofibroblasts 
that expressed NCAM and α-SMA. (B) Both NHNPC1 and NHNPC2 expressed α-SMA, Fibulin-2, 
Collagen-1 and Desmin but were negative for Gfap mRNA. (C) Flow cytometric analysis of NHNPCs 
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revealed that the frequency of polySia expression in NHNPCs was extremely low. (D) Schematic of 
the co-culture between NHNPC1 and BMOL. (E) Distance of migration (24 hours). Co-culture between 
NHNPC1 and BMOL with time lapse photography showed that BMOL migration was inhibited by 30% 
when polySia was cleaved with endoN (Supplemental videos 1 (control) and 2 (with endoN)). Scale 
bar = 100µm.                   
  
Figure 6. Analysis of the role of polySia during liver development. (A and B) HPC from E13.5 fetal 
HPCs expressed NCAM (A) and polySia (B). (C) H&E staining of wild type, St8sia2+/-4+/- mice and 
St8sia2-/-4-/- mice revealed grossly abnormal portal tracts in the knockout mice and normal portal tracts 
in the wild type mice. Immunohistochemistry for panCK revealed that the number of tube forming bile 
duct (bile ducts with typical morphology; black arrows) was less in St8sia2+/-4+/- and St8sia2-/-4-/- mice. 
(D) The frequency of tube forming bile ducts/portal area revealed a significant decrease in the number 
of tube forming bile duct in St8sia2+/-4+/- and St8sia2-/-4-/- mice compared to wild type mice. (E) 
Up-regulation of many biliary and HPC marker genes (Ck19, Ggt, Sox9, Prominin-1, and Ncam) could 
be detected in St8sia2-/-4-/- mice compared to wild type mice. Scale bar = 100µm               
 
Figure 7. Analysis of the role of polySia during DDC induced liver damage. (A) PanCK (DAB) staining 
revealed DRs/HPCs migrating into the parenchyma (black arrows) were more obvious in control group 
compared to endoN treated mice. (B) In endoN treated mice, DRs/HPCs migrating into 
parenchyma/portal area decreased significantly. (C) Anaysis of LW/BW ratio revealed a significant 
decrease of LW/BW ratio in endoN injected animals. (D) Serum blood test revealed only the serum 
ALT levels in endoN injection group were significantly elevated. (E) Real-time PCR analysis revealed 
that the mRNA levels of Ck19, Alb, Tat, Cps1 and Collagen-1 were significantly increased in endoN 
injection group. Scale bar = 100µm            
 
Figure 8. Overview of the role of NCAM and polySia-NCAM in the niche. 1) In niche NCAM-NCAM 
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homophilic cell adhesion and NCAM-matrix heterophilic interaction contribute the stable settlement of 
HPCs. 2) During migration in the HPC niche, polySia is produced mainly via ST8SiaIV from HPCs. 
PolySia weakens the cell-cell and cell-matrix interactions. In this context HPCs can move more easily. 
With polySia HGF is able to accelerate the migration of HPCs during regeneration. 3) During 
differentiation into hepatocytes, HGF and Wnt stimulation regulate polySia at the transcriptional level 
and OSM contributes to the cleavage of NCAM and polySia-NCAM from the cell surface. Therefore 
hepatocytes do not express NCAM. 
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SUPPLEMENTAL MATERIALS AND METHODS  
Human liver tissue 
We used archival cases of a chronic damaged liver caused by primary biliary cirrhosis (PBC), which 
was extirpated recipient livers from transplantation, and chronic damaged livers caused by hepatitis C 
and alcohol, which were resected for diagnosed HCC. Resected livers were analysed after their 
pathological diagnosis and receiving Institutional Review Board (IRB) approval from Niigata University. 
 
Immunostaining 
For immunohistochemistry, 10% formalin fixed tissue was cut to 5 μm were used. Where necessary, 
sections were antigen retrieved using heat mediated (10 mM sodium citrate buffer at PH6.0) or 
proteinase K enzymatic antigen retrieval. For DAB staining sections were blocked using 3% hydrogen 
peroxide for 10 minutes in room temperature (RT). Primary antibodies (Supplemental table 1) were 
incubated overnight at 4℃. Following this, species specific anti-IgG biotinylated antibodies were used 
for detection. Slides were then stained by Vectastain® ABC kit (Vector Laboratories, Inc. Burlingame, 
CA) and DAB substrate (DAKO, Glostroup, Denmark). Nuclei were stained using Mayer’s hematoxylin 
solution. For fluorescence immunohistochemistry, single staining for polySia and double staining for 
NCAM with panCK, sox9, α-SMA, desmin, GFAP, CD45 and laminin were performed. (Anti-panCK 
antibody can detect identical populations of bile ducts and DRs with anti-CK19 antibodies as shown in 
Supplemental figure1). For polySia single staining, the mouse on mouse MOM kit (Vector) was used 
as per the manufacturer’s protocol without antigen retrieval and then incubated with anti-polySia 
antibody followed by anti-mouse IgG Alexa555 conjugated antibody. For double fluorescence 
immunohistochemistry, NCAM antibodies were incubated overnight at 4℃. Sections were incubated 
with HRP conjugated anti-rabbit or rat IgG and detected by TSATM-plus Fluorescein System 
(PerkinElmer® Inc. Waltham, MA). Following this, tissues were stained as normal. Nuclei were labelled 
with DAPI mounting medium (SouthernBiotech, Birmingham, AL). For immunocytochemistry, cells 
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were washed with PBS, fixed with methanol at -20℃ for 10 minutes, and incubated with primary 
antibodies overnight at 4℃, and appropriate secondary antibodies for 30 minutes at RT. Nuclei were 
labelled with DAPI mounting medium. Photographs were taken using a Nikon Eclipse e600 
microscope and camera (DXM1200F) and acquired using NIS-Elements D software (Nikon, Tokyo, 
Japan). 
 
Histological analysis 
To determine whether there was a difference between wild type, St8sia2+/-4+/- and St8sia2-/-4-/- mice, 
tube forming bile ducts (bile ducts with typical morphology)/portal area were analysed (3-10 portal 
areas/section were counted; wild type mice = 6, St8sia2+/-4+/- mice = 7, St8sia2-/-4-/- mice = 12). To 
analyse the difference of migrated cells in the DDC diet endoN injection study, panCK+ cells migrating 
into the liver parenchyma/portal area were counted (5-10 portal areas/section were counted, control 
mice = 9, endoN injected mice = 10). To confirm the NCAM and polySia expression in long term 
damaged mouse livers, 8 weeks DDC damaged liver tissues were stained using anti-NCAM, 
anti-CK19 and anti-polySia antibodies. To confirm the NCAM and polySia expression in human chronic 
liver diseases cirrhotic liver tissues caused by HCV, alcohol and PBC were stained using anti-NCAM, 
anti-CK19 and anti-polySia antibodies.       
        
Western blot and co-immunoprecipitation    
Liver cells and tissues from mice collected by M-per® Mammalian Protein Extraction Reagent (Thermo 
Scientific, Rockfold, IL) and culture media supernatant were clarified by centrifugation. Positive control 
(P1.5 wild type neonatal mouse brain tissue lysate) and negative control (P1.5 NCAM knock out 
neonatal mouse brain tissue lysate) were provided by Professor Rita Gerardy-Schahn, Hannover 
University. To detect polySia, samples were denatured at 60℃ for 10 minutes (heating at high 
temperature destroys polySia). Proteins (20μg total protein per lane) were separated by NuPAGE 
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4-12% Bis-Tris Gel (Life Technologies, Grand Island, NY) and were electroblotted onto nitrocellulose 
membranes. Immunoblotting was carried out using primary antibodies (Supplemental table 1). Bound 
antibodies were detected using HRP conjugated species specific IgG and developed by ImmobilonTM 
Western chemiluminescent HRP substrate (MilliPore Corporation, Billerica, MA). β-actin was used as 
the loading control. Representative blots out of 3 or more independent experiments are shown. 
Co-immunoprecipitation was performed using Pierce® Crosslink Magnetic IP/Co-IP kit (Thermo 
Scientific) as manufacturer’s protocol. To confirm if NCAM is the binding protein of polySia, following 
immunoprecipitation for NCAM immunoprecipitates were analysed by western blot using anti-NCAM 
and anti-polySia antibody. Western blot using anti-NCAM antibody was performed with or without 
endoN.           
 
PCR 
Total RNA was isolated using RNAeasy Mini kit (Qiagen, Chatsworth, CA) according to the 
manufacturer’s protocol. RNA was reverse transcribed using QuantiTect reverse transcription kit 
(Qiagen). Gene expression analysis was achieved using pre-validated QuantiTech primers 
(Supplemental table 2) with Quantifast SYBR reagent (Qiagen). Real-time PCR was conducted using 
LightCycler 480 (Roche Applied Science, Mannheim, Germany). The results were obtained by at least 
3 separate samples. Ppia was used as a housekeeping gene. Fold change in relative gene expression 
from control was calculated using the ΔΔCT method with pooled control samples as a compartor.  
     
 
Cell Culture 
The HPC cell line BMOL was kindly provided by Prof George Yeoh, University of Western Australia 
and maintained in WilliamsE medium containing 2% FCS (Life Technologies) on poly-l-lysine coated 
plates. For establishment of 2 HPC lines, after liver digestion of CDE diet liver, non-parenchymal cells 
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were collected as previously reported1, 2. These cells were expanded crudely (HPC line 2) or after 
sorting CD133+EPCAM+CD24+ cells using a FACS aria II cell sorter (Becton Dickinson, San Jose, 
CA) (HPC line 3) in medium for HPC culture3. After HPC colonies formed (based upon morphology) 
these cells were maintained in HPC maintenance medium1 with 1% FCS supplemented with growth 
factors EGF (Peprotech, Rocky Hill, NJ, 20 ng/ml), bFGF (Miltenyi Biotec, Inc., Auburn, CA, 20 ng/ml) 
and HGF (Peprotech, 20 ng/ml). For establishment of NHNPC, after liver digestion of CDE diet liver, 
non-parenchymal cells were collected as previously reported1, 2. (We also tried to establish NHNPC 
using DDC diet damaged livers, however we could not establish.) These cells were expanded in 
medium for HPC culture3 and after that growing fibroblastic colonies were picked up and maintained in 
10% FCS containing WilliamsE medium with bFGF (20 ng/ml). All of these processes for 
establishment of HPC lines and NHNPCs were cultured using collagen-I coated plates. To harvest the 
BMOL cells for the following experiments diluted trypsin (500ml of PBS, 0.186g EDTA, 5ml of chicken 
serum (Sigma-Aldrich) and 5ml of 2.5% trypsin (Life Technologies) are mixed to make) that can keep 
polySia was used for 3 minutes. For the adhesion assay, cells were divided into two groups and 
cultured with endoN or without endoN overnight. 5x104 BMOL cells were seeded in 96-well plates 
precoated with laminin (20 μg/ml) for 30 minutes. Cells were washed, and adherent cells were fixed in 
5% glutaraldehyde (Sigma-Aldrich) and stained with 0.1% crystal violet. After dye solubilisation in 10% 
acetic acid, absorbance was measured at 570nm. For the expansion assay of BMOLs, 3 x 105 
cells/well were cultured with or without endoN and counted 3 days later using cell counter chamber. 
HGF (20 ng/ml) were used for these experiments. To confirm whether NCAM protein expression in 
BMOLs was affected by HGF induced cell expansion, 3 days culture with or without HGF at 0, 20 and 
50 ng/ml was performed and these cell lysates were examined by western blot for NCAM with endoN. 
For the aggregation assay, cells were cultured with or without endoN overnight. The cultured BMOLs 
were collected, washed 3 times and passed through a 27-gauge needle to make single cell 
suspension. Then, 2 x 105 cells/ml in 0.8% FCS contained PBS were incubated for 120 minutes in 15 
ml conical tubes. During that time, cells were gently mixed every 30 minutes. We counted the viable 
Page 36 of 54
Hepatology
Hepatology
Tsuchiya et al. 5 
single cells and total cells using cell counter chamber and analysed the frequency of single cells/total 
cells. During counting dead cells were excluded by trypan blue. To assay migration, we used OrisTM 
Cell Migration Assay kit (Platypus Technologies, LLC. Madison, WI) as per the manufacturer’s protocol. 
The area of migrating cells after 24 hours with or without endoN was calculated using Image J 
software. HGF (20 ng/ml) was used in this experiment. The results of all of these experiments were 
obtained from at least 4 separate experiments. For co-culture analysis, 6 x 105 NHNPC1 cells were 
seeded in 6 well collagen-I coated plates and cultured until they grew confluent. To stain BMOLs, 
PKH26 Red Fluorescent Cell linker for General Cell Membrane Labeling (Sigma-Aldrich) was used as 
per manufacturer’s protocol. The PKH26 stained (red) 2 x 105 BMOLs were cultured on a NHNPC1 
confluent cell monolayer with or without endoN. Pictures were taken every 20 minutes for 24 hours 
using Axio Obserber Z.1 (Carl Zeiss, Oberkochen, Germany) and distance of cell migration (randomly 
selected 60 cells of each group) was analysed. For differentiation of BMOLs towards hepatocytes, 3 x 
105 cells/well were cultured without growth factors or with Wnt3A (100 ng/ml, Peprotech), HGF (20 
ng/ml) or OSM (20 ng/ml, Sigma-Aldrich) for 1-4 days. For preparation of cell lysates and culture 
media supernatant for NCAM western blot, 6 x 105 cells/well were cultured for 24 hours with or without 
growth factors (20 ng/ml of HGF or 20 ng/ml of OSM). HPCs from E13.5 fetal livers used for 
immunocytochemistry for NCAM and polySia were established previously in our group1.                                  
 
Flow cytometry 
Cells were harvested with diluted trypsin (500ml of PBS, 0.186g EDTA, 5ml of chicken serum 
(Sigma-Aldrich) and 5ml of 2.5% trypsin (Life Technologies) are mixed to make) for 3 minutes to keep 
polySia. The resulting cells were incubated with anti-mouse CD16/32 antibody (Becton Dickinson) for 
15 minutes on ice to block non-specific binding. Cells were then incubated with antibodies 
(Supplemental table 1) for 30 minutes on ice. After washing, cells were analysed by FACSCaliber 
(Becton Dickinson). Results of flow cytometry were obtained by at least 3 separate samples and 
analysed using Flowing Software 2.3.3 (Cell Imaging Core, Turku Centre for Biotechnology, Finland).   
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EndoN 
For in vitro studies, endoN that was purchased from Eurobio Laboratories (AbC0020, CourtBoeuf 
Cedex, France) was employed according to the manufacturer’s protocol. For in vivo studies, endoN 
was kindly provided by Professor Rita Gerardy-Schahn (Hannover University). 10 μg/ml of endoN from 
Hannover University was added to the liver tissue lysate for lanes 2 and 4 of test series.  
  
Statistics 
Statistical analyses were performed using GraphPad Prism5 software (GraphPad Software, Inc., La 
Jolla, CA). Data are presented as mean±SD. The results were assessed using Mann-Whitney test. 
Differences were considered significant when the P-value was less than 0.05.  
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SUPPLEMENTAL FIGURE LEGENDS 
Supplemental figure 1. Comparison of staining pattern between anti-panCK and anti-CK19 
antibodies. Both antibodies detected the same bile ducts and DRs in DDC damaged livers. (A; serial 
section, B; immunofluorescence double immunohistochemistry.) Scale bar = 100μm (A and upper 
panels of B) and 50μm (lower panels of B). 
 
Supplemental figure 2. Characterization of NCAM+ cells in damaged livers by immunofluorescence 
staining. (A and B) Double immunofluorescence staining between NCAM and the ductular/HPC marker 
panCK (A) and sox9 (B) revealed that some cells of the bile duct and DR (A; yellow arrow) expressed 
NCAM. However some of the bile duct or DR surrounding cells (A and B; green arrows) also 
expressed NCAM. (C) Double immunofluorescence staining between NCAM and myofibroblast marker 
desmin revealed that some of the non-ductular NCAM+ cells were desmin+ myofibroblast (C; yellow 
arrows. Green arrows show desmin-/NCAM+ cells). (D and E) Double immunofluorescence staining 
between NCAM and stellate cell marker GFAP (D) and hematopoietic cell marker CD45 (E) revealed 
that NCAM+ cells were GFAP- and CD45-. Double immunofluorescence staining between NCAM and 
laminin showed that most of NCAM+ cells were in direct contact with laminin. Long term (8 weeks) 
DDC damaged liver also express NCAM (G) and polySia (H) in the same manner with short term DDC 
damaged livers shown in figure 1B and 2D. Scale bar = 50μm (A-C, G and H) and 100μm (D-F).            
            
Supplemental figure 3. NCAM and polySia expression of three HPC lines. (A and B) Both of HPC line 
2 and HPC line 3 expressed NCAM (green) and polySia (red). (C) The frequency of polySia in BMOLs 
was higher than that of other 2 cell lines. Scale bar = 100μm. 
 
Supplemental figure 4. Differentiation of BMOL to hepatocytes. (A-C) Following the differentiation of 
BMOLs to hepatocytes with Wnt3A (A) or OSM (C), the gene expression of Ck19 decreased, and the 
hepatocyte markers Alb increased significantly. (B) HGF which also induces expansion and migration 
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of BMOL has relatively weak differentiation induction ability compared to Wnt3A and OSM.    
     
Supplemental figure 5. Co-immunoprecipitation analysis. After immunoprecipitation of NCAM protein 
using anti-NCAM antibody, western blot for NCAM and polySia were performed using the 
immunoprecipitates. We could detect diffuse band around 200kDa which showed NCAM with polySia 
(arrow) when immunoprecipitates were blotted for NCAM and polySia. After the endo-N treatment the 
band was concentrated to 140kDa (arrowhead) when detected using anti-NCAM antibody. 
  
Supplemental figure 6. Characterization of NCAM and polySia expressing HPC cell line. (A) PCR 
analysis using BMOLs revealed that BMOLs expressed NCAM and the main enzyme that contributed 
to the production of polySia was ST8SiaIV. (B) Western blot analysis with endoN after addition of 
different concentration of HGF (0ng/ml, 20ng/ml and 50ng/ml; 3 days culture) showed that expansion 
by HGF did not affect the expression of NCAM protein.  
 
Supplemental figure 7. A schematic of results of mouse models with gene defects in the polyST. In 
wild type neonatal mouse liver many tube forming bile ducts (bile ducts with typical morphology) could 
be detected. The number of tube forming bile ducts decreased in both St8sia2+/-4+/- and St8sia2-/-4-/- 
mice, particularly in St8sia2-/-4-/- mice. 
  
Supplemental figure 8. A schematic to examine the effect of endoN in vivo. (A) A schematic of this 
study. EndoN or control was injected 4 times intraperitoneally into mice with DDC induced liver injury. 
(B) Test series of endoN injection resulted in the cleavage of polySia in the liver. Lanes 1 and 3 are 
liver tissue lysates from control injected mice. Lanes 2 and 4 are tissue lysates treated with endoN to 
lanes 1 and 3 respectively after protein extraction to confirm the activity of endoN as positive controls. 
Lanes 5-10 are endoN injected tissue lysates at different doses. In all endoN injected groups polySia 
was cleaved from the livers compared to control treated animals.  
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Supplemental figure 9. A schematic of endoN injection study using DDC diet liver damage mouse 
models. In control mice (without endoN injection) many DR cells migrated into the parenchyma. In 
contrast PolySia cleavage by intraperitoneal endoN injection resulted in a reduction in the number of 
DR cells migrating into liver parenchyma. 
 
Supplemental figure 10. Analysis of other possible polySia binding proteins in the liver by 
immunostaining. (A-F) Both MARCKS and neuropilin-2 could not be detected in bile ducts or DRs in 
CDE and DDC diet damaged livers and BMOL HPC line. Endothelial cells in CDE and DDC diet 
damaged livers are positive for neuropilin-2. Scale bar = 50μm (A-D) and 100μm (E and F).    
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IHC, immunohistochemistry; ICC, immunocytochemistry; WB, western blot; FACS, flow cytometry 
Table 1. Primary antibodies used in this study.  
Primary antibody         Species        Source              Dilution    
Mouse NCAM 
Mouse NCAM (H28) 
polySia (735) 
polySia 
cytokeratin19 
PanCK 
Sox 9 
α-SMA 
Desmin 
GFAP 
CD45 
Laminin 
MARCKS 
Neuropilin-2 
β-actin 
Rabbit 
Rat 
Mouse 
Mouse 
Rat 
Rabbit 
Rabbit 
Mouse 
Rabbit 
Rabbit 
Rat 
Rabbit 
Rabbit 
Rabbit 
Rabbit 
IHC, ICC, 1/50; WB, 1/1000 
IHC, ICC, 1/100; WB1/1000 
IHC, 1/500  
ICC, 1/10; FACS, 1/30 
1/200 
1/200 
1/100 
1/500 
1/50 
1/500 
1/100 
IHC, 1/25 
IHC,ICC, 1/100  
IHC,ICC, 1/100 
1/5000 
  
ProteinTech 
Gifted (Hannover Univ)
Gifted (Hannover Univ) 
Miltenyi Biotec 
Developmental Studies Hybridoma Bank 
DAKO 
MILLIPORE 
Sigma-Aldrich 
Abcam 
Abcam 
R&D systems 
Abcam 
Abcam 
Cell Signaling 
Sigma-Aldrich  
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57
58
59
60
Table 2. PCR primers used in this study. 
 
 
Name                Identification number 
Ncam 
St8sia2 
St8sia4 
Ck19 
Ggt 
Alb 
Prominin-1 
Sox 9 
Epcam 
Tat 
Cps1 
To 
G6p 
Cyp1a2 
Cyp2a12 
α-sma 
Fibulin-2 
Collagen 1a2 
Desmin 
Gfap 
Ppia 
QT01065064 
QT00099750 
QT00165522 
QT00156667 
QT00104209 
QT00115570 
QT01065162 
QT00163765 
QT02304456 
QT00112833 
QT01049041 
QT00150409 
QT00114625 
QT00100674 
QT00115619 
QT00140119 
QT00145943 
QT02325736 
QT00102333 
QT00101143 
QT00247709 
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